Danhui Co-creates a Comprehensive Solution for Varicose Veins: Showcasing Exclusive Technology at the Central Plains Vascular Conference

The 2025 Central Plains Vascular Conference (CPEC2025) concluded successfully in Zhengzhou, Henan, from July 24 to 26. As a key academic platform in the field of vascular surgery, this conference focused on the exchange and exploration of solutions to clinical challenges. Danhui Co-creation participated in the conference with its "Comprehensive Solution for Varicose Veins", which centers on perforator vein treatment.

As a participant in the conference, the innovative achievements of Danhui Co-creation sparked extensive discussions. Among them, the microwave ablation solution for perforator vein treatment became a highlight of the venous session due to its alignment with clinical pain points — the independently developed rigid ablation catheter in the solution can accurately reach the lesion under ultrasound guidance, effectively solving the operational problems of "easy bending and positioning deviation" with traditional instruments, and providing a more suitable technical option for perforator vein treatment.

In the conference’s special sharing session "Application of Rigid Ablation Catheters in the Treatment of Pathological Perforator Veins in Lower Extremity Varicose Veins", Professor Yu Haibin from the Second Affiliated Hospital of Zhengzhou University, combined with clinical practice, in-depth interpreted the operational advantages of the self-developed rigid ablation catheter by Danhui. This provided practical references for participating peers and further highlighted the clinical application value of this technology.

R&D Center Localization Drives Technological Upgrades

Innovative Core Strength

Guided by Clinical Needs

At this conference, Danhui Medical's technological achievements and R&D capabilities were highly recognized by industry peers. In the future, Danhui Medical will continue to be guided by clinical needs, transform insights from academic exchanges into motivation for technological upgrades, and continuously optimize product performance. This will bring safer and more efficient treatment experiences to patients with lower extremity varicose veins, helping vascular interventional technology reach new heights.